Guardant Health, Inc. (GH)
Guardant Health, Inc. (GH) is a Healthcare stock tracked by StreetAlpha. GH reports earnings on Wed, Oct 28, 2026. The average 12-month price target from 17 analysts is $199.47, with a high of $225.00 and a low of $180.00. Analyst consensus is Strong Buy, based on the latest ratings from 17 firms (17 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 5 whale options trades in GH, 40% of them bullish and 60% bearish. In the past 30 days there were 10 dark pool prints totaling $8.6M, the largest $1.7M.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 17 analysts who set a price target on GH in the past 90 days. The average target is $199.47, with a high of $225.00 and a low of $180.00.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 1 | Guggenheim | Target raised | Buy | $190 → $200 |
| Sep 9 | UBS | Maintained | Buy | $225 |
| Sep 8 | Rothschild & Co | Initiated | Buy | $203 |
| Sep 2 | BTIG | Reiterated | Buy | $195 |
| Aug 4 | Piper Sandler | Maintained | Buy | $193 |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GH is in one of them and how their past GH trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered GH in an article yet. Here's the latest on the wider market.
For informational purposes only. Not financial advice. Options flow and dark pool data are delayed and may be incomplete.